Published in
Esmo Open, Esmo Open, 4(5), p. e000774, 2020
DOI: 10.1136/esmoopen-2020-000774
Links
Tools
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group
Journal article published in 2020 by
Elena Fountzilas 
,
Georgia-Angeliki Koliou,
Athanassios Vozikis,
Vassiliki Rapti,
Achilleas Nikolakopoulos,
Anastasios Boutis,
Athina Christopoulou,
Ioannis Kontogiorgos,
Sofia Karageorgopoulou,
Efthalia Lalla,
Dimitrios Tryfonopoulos,
Ioannis Boukovinas,
Cleopatra Rapti,
Adamantia Nikolaidi,
Sofia Karteri
and other authors.
,
Georgia-Angeliki Koliou,
Athanassios Vozikis,
Vassiliki Rapti,
Achilleas Nikolakopoulos,
Anastasios Boutis,
Athina Christopoulou,
Ioannis Kontogiorgos,
Sofia Karageorgopoulou,
Efthalia Lalla,
Dimitrios Tryfonopoulos,
Ioannis Boukovinas,
Cleopatra Rapti,
Adamantia Nikolaidi,
Sofia Karteri
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 